Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New president for Spain’s FENIN

This article was originally published in SRA

Executive Summary

Victoriano Prim Gonz�lez has stepped down as president of FENIN, the Spanish medical technology industry federation, swapping positions with hitherto vice president Carmelo Sanz. Mr Sanz, the president of Becton Dickinson for Spain, Portugal and Latin America, will hold the presidency until FENIN elections at the end of 2010. As president, he will continue the strategies set out by Mr Prim Gonz�lez, specifically promoting the value of medical technology and fostering innovation in the sector.

You may also be interested in...



Pharma Guidelines, ending 1 July 2011

Recently updated and newly issued documents

EuropaBio appoints new chairman

EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.

Medtech Guidelines, ending 24 June 2011

Recently updated and newly issued documents

UsernamePublicRestriction

Register

PS114699

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel